Vaccine Induction of Heterologous HIV-1 Neutralizing Antibody B Cell Lineages in Humans
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
A study of vaccine-induced HIV-1 gp41 MPER-reactive B cell responses in humans.
应用场景：
创建时间：
2024-03-28
相关数据集
CHIP-Seq analysis of CREB1 binding after ALVAC vaccination in Human PBMC. CHIP-Seq analysis of CREB1 binding after ALVAC vaccination in Human PBMC
The RV144 HIV vaccine trial remains the only study to demonstrate significant protection from future HIV-1 acquisition. One of the key components of the RV144 vaccine was the use of the canarypox vect
NIAID Data Ecosystem60
Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies
A fundamental challenge for developing an effective and safe HIV-1 vaccine is to identify vaccine immunogens that can initiate and maintain immune responses leading to elicitation of broadly neutraliz
Figshare2016-01-15 更新40
Table_1_Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity.XLSX
Exploring the characteristics of the HIV-1 envelope glycoprotein (env) gene in a natural HIV-1 infected individual, with broadly neutralizing activity, may provide insight into the generation of such
NIAID Data Ecosystem10
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-
Protein Data Bank Japan2024-10-23 更新40
Targeting human langerin promotes HIV-1 specific humoral immune responses. Targeting human langerin promotes HIV-1 specific humoral immune responses
The main avenue for the development of an HIV-1 vaccine remains the induction of protective antibodies. A rationale approach is to target antigen to specific receptors on dendritic cells (DC) via fuse
NIAID Data Ecosystem10
